サマリー

ラテンアメリカの片頭痛治療薬世界市場 2023-2027
Technavioはラテンアメリカの片頭痛薬市場を監視しており、2023年から2027年の間に8231万ドルの成長が見込まれ、予測期間中にCAGR 5.82%で加速しています。当レポートでは、中南米の片頭痛治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の地域別市場シナリオ、最新動向と推進要因、市場全体の環境に関する最新分析を提供しています。市場は、中南米における片頭痛の有病率の増加、片頭痛治療啓発プログラムの増加、薬剤の再製剤化によって牽引されています。
Technavioのラテンアメリカの片頭痛薬市場は、以下のように区分されています。
エンドユーザー別
- 病院
- 小売
- オンライン
本調査では、今後数年間におけるラテンアメリカの片頭痛治療薬市場の成長を促進する主な理由の1つとして、より高い臨床効果を持つ新クラスの薬剤の導入を挙げています。また、片頭痛治療用機器の人気の上昇と片頭痛治療薬の進歩の高まりは、市場の大規模な需要につながるでしょう。
Technavioは、主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括の方法により、市場の詳細な姿を提示します。中南米の片頭痛治療薬市場に関する当レポートでは、以下の分野をカバーしています。
- ラテンアメリカの片頭痛治療薬市場規模予測
- 中南米の片頭痛治療薬市場予測
- 中南米の片頭痛治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、ラテンアメリカの片頭痛治療薬市場の主要ベンダー（AbbVie Inc、Amgen Inc、Amneal Pharmaceuticals Inc、Bausch Health Co.、Bayer AG、第一三共Inc.Ltd.、Dr. Reddys Laboratories Ltd.、Eli Lilly and Co.、Endo International Plc、Ethypharm SAS、GlaxoSmithKline Plc、H Lundbeck AS、IntelGenx Technologies Corp.、Klaria Pharma Holding AB、興亜 Co.Ko.Ka、OptiNose Inc.Ltd.、OptiNose Inc.、Pfizer Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、およびUCB SAです。また、ラテンアメリカの片頭痛薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/latin-america-migraine-drugs-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Latin America - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Latin America: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
• 4 Historic Market Size
o 4.1 Migraine Drugs Market in Latin America 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Migraine Drugs Market in Latin America 2017 - 2021 ($ million)
o 4.2 Therapy Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.3 End-User Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
o 4.4 Country Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 22: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 25: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 26: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 27: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 28: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 29: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 30: Data Table on Therapy - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 31: Chart on Comparison by Therapy
o Exhibit 32: Data Table on Comparison by Therapy
o 6.3 Preventive treatment - Market size and forecast 2022-2027
o Exhibit 33: Chart on Preventive treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 34: Data Table on Preventive treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Chart on Preventive treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Preventive treatment - Year-over-year growth 2022-2027 (%)
o 6.4 Abortive treatment - Market size and forecast 2022-2027
o Exhibit 37: Chart on Abortive treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Data Table on Abortive treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Chart on Abortive treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 40: Data Table on Abortive treatment - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Therapy
o Exhibit 41: Market opportunity by Therapy ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 42: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 43: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 44: Chart on Comparison by End-user
o Exhibit 45: Data Table on Comparison by End-user
o 7.3 Hospital - Market size and forecast 2022-2027
o Exhibit 46: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 7.4 Retail - Market size and forecast 2022-2027
o Exhibit 50: Chart on Retail - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Retail - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Retail - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Retail - Year-over-year growth 2022-2027 (%)
o 7.5 Online - Market size and forecast 2022-2027
o Exhibit 54: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 55: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 57: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 58: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 60: Chart on Market share by geography - 2022-2027 (%)
o Exhibit 61: Data Table on Market share by geography - 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 62: Chart on Geographic comparison
o Exhibit 63: Data Table on Geographic comparison
o 9.3 Mexico - Market size and forecast 2022-2027
o Exhibit 64: Chart on Mexico - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Mexico - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Mexico - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
o 9.4 Brazil - Market size and forecast 2022-2027
o Exhibit 68: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Brazil - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
o 9.5 Argentina - Market size and forecast 2022-2027
o Exhibit 72: Chart on Argentina - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Data Table on Argentina - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Chart on Argentina - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Argentina - Year-over-year growth 2022-2027 (%)
o 9.6 Chile - Market size and forecast 2022-2027
o Exhibit 76: Chart on Chile - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Data Table on Chile - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Chart on Chile - Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Chile - Year-over-year growth 2022-2027 (%)
o 9.7 Rest of Latin America - Market size and forecast 2022-2027
o Exhibit 80: Chart on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Data Table on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Chart on Rest of Latin America - Year-over-year growth 2022-2027 (%)
o Exhibit 83: Data Table on Rest of Latin America - Year-over-year growth 2022-2027 (%)
o 9.8 Market opportunity by geography
o Exhibit 84: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 85: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 86: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 87: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 88: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 89: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 90: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 91: AbbVie Inc. - Overview
o Exhibit 92: AbbVie Inc. - Product / Service
o Exhibit 93: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 94: Amgen Inc. - Overview
o Exhibit 95: Amgen Inc. - Product / Service
o Exhibit 96: Amgen Inc. - Key offerings
o 12.5 Amneal Pharmaceuticals Inc.
o Exhibit 97: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 98: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 99: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 100: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 101: Amneal Pharmaceuticals Inc. - Segment focus
o 12.6 Bayer AG
o Exhibit 102: Bayer AG - Overview
o Exhibit 103: Bayer AG - Business segments
o Exhibit 104: Bayer AG - Key offerings
o Exhibit 105: Bayer AG - Segment focus
o 12.7 Daiichi Sankyo Co. Ltd.
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 107: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 108: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 109: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 110: Daiichi Sankyo Co. Ltd. - Segment focus
o 12.8 Eli Lilly and Co.
o Exhibit 111: Eli Lilly and Co. - Overview
o Exhibit 112: Eli Lilly and Co. - Product / Service
o Exhibit 113: Eli Lilly and Co. - Key offerings
o 12.9 Endo International Plc
o Exhibit 114: Endo International Plc - Overview
o Exhibit 115: Endo International Plc - Business segments
o Exhibit 116: Endo International Plc - Key news
o Exhibit 117: Endo International Plc - Key offerings
o Exhibit 118: Endo International Plc - Segment focus
o 12.10 GlaxoSmithKline Plc
o Exhibit 119: GlaxoSmithKline Plc - Overview
o Exhibit 120: GlaxoSmithKline Plc - Business segments
o Exhibit 121: GlaxoSmithKline Plc - Key offerings
o Exhibit 122: GlaxoSmithKline Plc - Segment focus
o 12.11 H Lundbeck AS
o Exhibit 123: H Lundbeck AS - Overview
o Exhibit 124: H Lundbeck AS - Product / Service
o Exhibit 125: H Lundbeck AS - Key offerings
o 12.12 IntelGenx Technologies Corp.
o Exhibit 126: IntelGenx Technologies Corp. - Overview
o Exhibit 127: IntelGenx Technologies Corp. - Product / Service
o Exhibit 128: IntelGenx Technologies Corp. - Key offerings
o 12.13 Klaria Pharma Holding AB
o Exhibit 129: Klaria Pharma Holding AB - Overview
o Exhibit 130: Klaria Pharma Holding AB - Product / Service
o Exhibit 131: Klaria Pharma Holding AB - Key offerings
o 12.14 Kowa Co. Ltd.
o Exhibit 132: Kowa Co. Ltd. - Overview
o Exhibit 133: Kowa Co. Ltd. - Product / Service
o Exhibit 134: Kowa Co. Ltd. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 135: Pfizer Inc. - Overview
o Exhibit 136: Pfizer Inc. - Product / Service
o Exhibit 137: Pfizer Inc. - Key news
o Exhibit 138: Pfizer Inc. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 139: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 140: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 141: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 142: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 143: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 UCB SA
o Exhibit 144: UCB SA - Overview
o Exhibit 145: UCB SA - Product / Service
o Exhibit 146: UCB SA - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 147: Inclusions checklist
o Exhibit 148: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 149: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 150: Research methodology
o Exhibit 151: Validation techniques employed for market sizing
o Exhibit 152: Information sources
o 13.5 List of abbreviations
o Exhibit 153: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Latin America - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Latin America: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits18: Historic Market Size - Data Table on Migraine Drugs Market in Latin America 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits22: Five forces analysis - Comparison between 2022 and 2027
Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits25: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits26: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits27: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits28: Chart on Market condition - Five forces 2022 and 2027
Exhibits29: Chart on Therapy - Market share 2022-2027 (%)
Exhibits30: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits31: Chart on Comparison by Therapy
Exhibits32: Data Table on Comparison by Therapy
Exhibits33: Chart on Preventive treatment - Market size and forecast 2022-2027 ($ million)
Exhibits34: Data Table on Preventive treatment - Market size and forecast 2022-2027 ($ million)
Exhibits35: Chart on Preventive treatment - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Preventive treatment - Year-over-year growth 2022-2027 (%)
Exhibits37: Chart on Abortive treatment - Market size and forecast 2022-2027 ($ million)
Exhibits38: Data Table on Abortive treatment - Market size and forecast 2022-2027 ($ million)
Exhibits39: Chart on Abortive treatment - Year-over-year growth 2022-2027 (%)
Exhibits40: Data Table on Abortive treatment - Year-over-year growth 2022-2027 (%)
Exhibits41: Market opportunity by Therapy ($ million)
Exhibits42: Chart on End-user - Market share 2022-2027 (%)
Exhibits43: Data Table on End-user - Market share 2022-2027 (%)
Exhibits44: Chart on Comparison by End-user
Exhibits45: Data Table on Comparison by End-user
Exhibits46: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Retail - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Retail - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Retail - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Retail - Year-over-year growth 2022-2027 (%)
Exhibits54: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits58: Market opportunity by End-user ($ million)
Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits60: Chart on Market share by geography - 2022-2027 (%)
Exhibits61: Data Table on Market share by geography - 2022-2027 (%)
Exhibits62: Chart on Geographic comparison
Exhibits63: Data Table on Geographic comparison
Exhibits64: Chart on Mexico - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Mexico - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Brazil - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Argentina - Market size and forecast 2022-2027 ($ million)
Exhibits73: Data Table on Argentina - Market size and forecast 2022-2027 ($ million)
Exhibits74: Chart on Argentina - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Argentina - Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Chile - Market size and forecast 2022-2027 ($ million)
Exhibits77: Data Table on Chile - Market size and forecast 2022-2027 ($ million)
Exhibits78: Chart on Chile - Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Chile - Year-over-year growth 2022-2027 (%)
Exhibits80: Chart on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
Exhibits81: Data Table on Rest of Latin America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Chart on Rest of Latin America - Year-over-year growth 2022-2027 (%)
Exhibits83: Data Table on Rest of Latin America - Year-over-year growth 2022-2027 (%)
Exhibits84: Market opportunity by geography ($ million)
Exhibits85: Impact of drivers and challenges in 2022 and 2027
Exhibits86: Overview on Criticality of inputs and Factors of differentiation
Exhibits87: Overview on factors of disruption
Exhibits88: Impact of key risks on business
Exhibits89: Vendors covered
Exhibits90: Matrix on vendor position and classification
Exhibits91: AbbVie Inc. - Overview
Exhibits92: AbbVie Inc. - Product / Service
Exhibits93: AbbVie Inc. - Key offerings
Exhibits94: Amgen Inc. - Overview
Exhibits95: Amgen Inc. - Product / Service
Exhibits96: Amgen Inc. - Key offerings
Exhibits97: Amneal Pharmaceuticals Inc. - Overview
Exhibits98: Amneal Pharmaceuticals Inc. - Business segments
Exhibits99: Amneal Pharmaceuticals Inc. - Key news
Exhibits100: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits101: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits102: Bayer AG - Overview
Exhibits103: Bayer AG - Business segments
Exhibits104: Bayer AG - Key offerings
Exhibits105: Bayer AG - Segment focus
Exhibits106: Daiichi Sankyo Co. Ltd. - Overview
Exhibits107: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits108: Daiichi Sankyo Co. Ltd. - Key news
Exhibits109: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits110: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits111: Eli Lilly and Co. - Overview
Exhibits112: Eli Lilly and Co. - Product / Service
Exhibits113: Eli Lilly and Co. - Key offerings
Exhibits114: Endo International Plc - Overview
Exhibits115: Endo International Plc - Business segments
Exhibits116: Endo International Plc - Key news
Exhibits117: Endo International Plc - Key offerings
Exhibits118: Endo International Plc - Segment focus
Exhibits119: GlaxoSmithKline Plc - Overview
Exhibits120: GlaxoSmithKline Plc - Business segments
Exhibits121: GlaxoSmithKline Plc - Key offerings
Exhibits122: GlaxoSmithKline Plc - Segment focus
Exhibits123: H Lundbeck AS - Overview
Exhibits124: H Lundbeck AS - Product / Service
Exhibits125: H Lundbeck AS - Key offerings
Exhibits126: IntelGenx Technologies Corp. - Overview
Exhibits127: IntelGenx Technologies Corp. - Product / Service
Exhibits128: IntelGenx Technologies Corp. - Key offerings
Exhibits129: Klaria Pharma Holding AB - Overview
Exhibits130: Klaria Pharma Holding AB - Product / Service
Exhibits131: Klaria Pharma Holding AB - Key offerings
Exhibits132: Kowa Co. Ltd. - Overview
Exhibits133: Kowa Co. Ltd. - Product / Service
Exhibits134: Kowa Co. Ltd. - Key offerings
Exhibits135: Pfizer Inc. - Overview
Exhibits136: Pfizer Inc. - Product / Service
Exhibits137: Pfizer Inc. - Key news
Exhibits138: Pfizer Inc. - Key offerings
Exhibits139: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits140: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits141: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits142: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits143: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits144: UCB SA - Overview
Exhibits145: UCB SA - Product / Service
Exhibits146: UCB SA - Key offerings
Exhibits147: Inclusions checklist
Exhibits148: Exclusions checklist
Exhibits149: Currency conversion rates for US$
Exhibits150: Research methodology
Exhibits151: Validation techniques employed for market sizing
Exhibits152: Information sources
Exhibits153: List of abbreviations